当前位置：
X-MOL 学术
›
J. Allergy Clin. Immunol. Pract.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Rituximab and infliximab desensitization with anti-IgE mAb omalizumab as adjuvant therapy: a case series
The Journal of Allergy and Clinical Immunology: In Practice ( IF 8.2 ) Pub Date : 2022-09-08 , DOI: 10.1016/j.jaip.2022.08.036 Margherita Perlato 1 , Valentina Mecheri 1 , Matteo Accinno 1 , Emanuele Vivarelli 2 , Andrea Matucci 2 , Alessandra Vultaggio 2
The Journal of Allergy and Clinical Immunology: In Practice ( IF 8.2 ) Pub Date : 2022-09-08 , DOI: 10.1016/j.jaip.2022.08.036 Margherita Perlato 1 , Valentina Mecheri 1 , Matteo Accinno 1 , Emanuele Vivarelli 2 , Andrea Matucci 2 , Alessandra Vultaggio 2
Affiliation
Abstract not available
中文翻译：
抗 IgE mAb omalizumab 作为辅助治疗的利妥昔单抗和英夫利昔单抗脱敏：病例系列
摘要不可用
更新日期：2022-09-08
中文翻译：
抗 IgE mAb omalizumab 作为辅助治疗的利妥昔单抗和英夫利昔单抗脱敏：病例系列
摘要不可用
京公网安备 11010802027423号